HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel Biomedical Functions of Surfactin A from Bacillus subtilis in Wound Healing Promotion and Scar Inhibition.

Abstract
Surfactin produced by Bacillus subtilis is a powerful biosurfactant in food, cosmetics, and pesticide industries. However, its suitability in wound healing applications is uncertain. In this article, we determined the effects of surfactin A from B. subtilis on wound healing, angiogenesis, cell migration, inflammatory response, and scar formation. The results indicated that 80.65 ± 2.03% of surfactin A-treated wounds were closed, whereas 44.30 ± 4.26% of the vehicle-treated wound areas remained open on day 7 (P < 0.05). In mechanisms, it upregulated the expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF), accelerated keratinocyte migration through mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) signaling pathways, and regulated the secretion of proinflammatory cytokines and macrophage phenotypic switch. More attractive, surfactin A showed a seductive capability to inhibit scar tissue formation by affecting the expression of α-smooth muscle actin (α-SMA) and transforming growth factor (TGF-β). Overall, the study revealed a new function and potential of surfactin A as an affordable and efficient wound healing drug.
AuthorsLu Yan, Guanwen Liu, Bin Zhao, Bing Pang, Wanqin Wu, Chongyang Ai, Xixi Zhao, Xinglong Wang, Chunmei Jiang, Dongyan Shao, Qianlong Liu, Meixuan Li, Lei Wang, Junling Shi
JournalJournal of agricultural and food chemistry (J Agric Food Chem) Vol. 68 Issue 26 Pg. 6987-6997 (Jul 01 2020) ISSN: 1520-5118 [Electronic] United States
PMID32412748 (Publication Type: Journal Article)
Chemical References
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Lipopeptides
  • NF-kappa B
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • surfactin A
Topics
  • Animals
  • Bacillus subtilis (chemistry, metabolism)
  • Cicatrix (drug therapy, genetics, metabolism, physiopathology)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Lipopeptides (metabolism, pharmacology)
  • Male
  • Mice
  • NF-kappa B (genetics, metabolism)
  • Transforming Growth Factor beta (metabolism)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: